Nicolas Hart/X
Jun 3, 2025, 14:39
Nicolas Hart: CHALLENGE trial at ASCO25 – Standing Ovation for Exercise Impact on Cancer Outcomes
Nicolas Hart, Associate Professor and Program Director at University of Technology Sydney, shared a post on X:
“A standing ovation for CHALLENGE trial at ASCO25 – first in world to definitively show exercise reduces recurrence and improves survival:
‘For every 16 people, exercise prevents 1 person from recurrent/new cancer’
‘For every 14 people, exercise prevents 1 person from dying’.”
Read OncoDaily’s Special Articles about ASCO 2025:
Highlights from ASCO 2025 Day 1
Highlights from ASCO 2025 Day 2
Highlights from ASCO 2025 Day 3
Highlights from ASCO 2025 Day 4
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 30, 2025, 13:38
Aug 30, 2025, 13:34
Aug 30, 2025, 13:25
Aug 30, 2025, 11:47
Aug 30, 2025, 06:58
Aug 30, 2025, 06:33
Aug 29, 2025, 22:14
Aug 29, 2025, 22:06
Aug 29, 2025, 21:55
Aug 29, 2025, 20:40